[{"source": "PMC", "date": "20240127", "key": "pmc.key", "infons": {}, "documents": [{"id": "10598793", "infons": {"license": "CC BY"}, "passages": [{"offset": 0, "infons": {"article-id_doi": "10.1021/acs.jcim.3c01096", "article-id_pmc": "10598793", "article-id_pmid": "37722101", "fpage": "6239", "issue": "20", "license": "Permits the broadest form of re-use including for commercial purposes, provided that author attribution and integrity are maintained (https://creativecommons.org/licenses/by/4.0/).", "lpage": "6248", "name_0": "surname:Buehler;given-names:Ye", "name_1": "surname:Reymond;given-names:Jean-Louis", "section_type": "TITLE", "type": "front", "volume": "63", "year": "2023"}, "text": "Expanding Bioactive Fragment Space with the Generated Database GDB-13s", "sentences": [], "annotations": [], "relations": []}, {"offset": 71, "infons": {"section_type": "ABSTRACT", "type": "abstract"}, "text": "Identifying innovative fragments for drug design can help medicinal chemistry address new targets and overcome the limitations of the classical molecular series. By deconstructing molecules into ring fragments (RFs, consisting of ring atoms plus ring-adjacent atoms) and acyclic fragments (AFs, consisting of only acyclic atoms), we find that public databases of molecules (i.e., ZINC and PubChem) and natural products (i.e., COCONUT) contain mostly RFs and AFs of up to 13 atoms. We also find that many RFs and AFs are enriched in bioactive vs inactive compounds from ChEMBL. We then analyze the generated database GDB-13s, which enumerates 99 million possible molecules of up to 13 atoms, for RFs and AFs resembling ChEMBL bioactive RFs and AFs. This analysis reveals a large number of novel RFs and AFs that are structurally simple, have favorable synthetic accessibility scores, and represent opportunities for synthetic chemistry to contribute to drug innovation in the context of fragment-based drug discovery.", "sentences": [], "annotations": [], "relations": []}, {"offset": 1088, "infons": {"section_type": "INTRO", "type": "title_1"}, "text": "Introduction", "sentences": [], "annotations": [], "relations": []}, {"offset": 1101, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Medicinal chemistry becomes an increasingly retrospective activity as public databases such as PubChem and ChEMBL list increasing numbers of known drug-like molecules and their biological activity, from which new analogues can be derived. Nevertheless, introducing chemical novelty in new drugs is important because it can help to address new target types and overcome the limitations of classical molecular series in terms of physicochemical properties, selectivity, toxicity, and metabolism, as well as to secure intellectual property and the possibility of commercial development.\u2212 Currently, innovation focuses on exploiting very large libraries of screening compounds obtained by combining known building blocks using known chemistry. These libraries contain billions of molecules, as in ZINC or the Enamine REAL database, up to hundreds of billions of molecules in DNA encoded libraries,\u2212 or even much larger numbers of peptides and cyclic peptides in phage or ribosome display libraries. Such molecules often break Lipinski\u2019s rule of five but can nevertheless be developed as drugs.", "sentences": [], "annotations": [], "relations": []}, {"offset": 2197, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Despite the impressive numbers of molecules in the above-mentioned databases, these molecules are obtained by combining a limited set of building blocks, typically up to thousands (only 20 for genetically encoded peptides), which severely limits fragment diversity. With respect to fragments, an additional, potentially more important, but mostly unexploited reservoir of novelty exists in the generated databases (GDBs), which systematically enumerate molecules of up to 11, 13, or 17 non-hydrogen atoms (heavy atom count (HAC) = 11, 13, or 17) from mathematical graphs using simple rules of chemical stability and synthetic feasibility.\u2212 For instance, the GDBs feature molecules with many unprecedented molecular frameworks (graphs including rings and linker bonds).", "sentences": [], "annotations": [], "relations": []}, {"offset": 2968, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "Here, we propose an approach to identify novel fragments from the GDBs that could be useful for drug design by taking the accumulated knowledge of bioactive compounds into account through an analysis of fragments. First, we assess the known chemical space by deconstructing molecules in the public databases ZINC (screening compounds), PubChem (published molecules), and COCONUT (natural products and NP-like molecules) into ring fragments (RFs, obtained by removing all atoms not directly connected to a ring) and acyclic fragments (AFs, obtained by removing all ring atoms) (Figure 1). This fragmentation is inspired by computational retrosynthetic analyses such as RECAP, rdScaffoldNetwork, DAIM, BRICS, CCQ, eMolFrag, molBLOCKS, or Fragmenter. In the present context, our deconstruction into RFs and AFs is designed to simplify molecules and focus on structural types. Interestingly, most molecules in ZINC, PubChem, and COCONUT break down into RFs and AFs of 13 atoms or less.", "sentences": [], "annotations": [], "relations": []}, {"offset": 3950, "infons": {"file": "ci3c01096_0001.jpg", "id": "fig1", "section_type": "FIG", "type": "fig_caption"}, "text": "Fragmentation of molecules into ring fragments\n(RFs) and acyclic\nfragments (AFs). The general principle is given in the example of\nthe drug gefitinib. For RFs, acyclic atoms are labeled in red.", "sentences": [], "annotations": [], "relations": []}, {"offset": 4144, "infons": {"section_type": "INTRO", "type": "paragraph"}, "text": "In the second part of our approach, we identify RFs and AFs which are strongly enriched in bioactivity compared to inactive molecules in ChEMBL (target annotated compounds) and search for analogues of these fragments in RFs and AFs derived from the generated database GDB-13s. This database is a 10% subset of the database GDB-13, which lists 970 million small molecules of up to 13 atoms exhaustively enumerated from mathematical graphs following the simple rules of chemical stability and synthetic feasibility. While GDB-13 excludes strained rings (e.g., cubane and prismane) and hydrolytically labile and reactive functional groups (e.g., hemiacetals, aminals, enols, acyl chlorides, isocyanides, peroxides, azides, and thiols) and only considers C, N, O, S, and Cl as elements, GDB-13s additionally excludes non-aromatic olefins, acetals, enol ethers, aziridines, and aldehydes, which only rarely occur in drug molecules. Nevertheless, GDB-13s contains many unprecedented molecular frameworks (graphs including rings and linker bonds). In the present analysis, we find that many of the bioactive-like RFs and AFs identified in GDB-13s are structurally relatively simple and have favorable synthetic accessibility scores (SAscores) and therefore represent opportunities for synthetic chemistry to contribute to drug innovation in the context of fragment-based drug discovery.", "sentences": [], "annotations": [], "relations": []}, {"offset": 5524, "infons": {"section_type": "RESULTS", "type": "title_1"}, "text": "Results and Discussion", "sentences": [], "annotations": [], "relations": []}, {"offset": 5547, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "Fragment Analysis of Known Molecules and GDB-13s", "sentences": [], "annotations": [], "relations": []}, {"offset": 5596, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "To assess the known chemical space, we extracted RFs and AFs from 885\u202f905\u202f524 molecules in the ZINC database, 100\u202f852\u202f694 molecules of up to 50 non-hydrogen atoms in PubChem, and 401\u202f624 natural products (NPs) and NP-like molecules in COCONUT. We also extracted RFs and AFs from the 99\u202f394\u202f177 molecules in GDB-13s, to be used as a source of novelty later in the study. In all these databases, the number of molecules per RF and AF followed a typical power law distribution, with few RFs and AFs occurring in many molecules and a relatively large number of RFs and AFs occurring only once, referred to as singletons (Figures 2a and 2b and Table 1). The most frequent RFs and AFs in each database were rather small, featuring mono- and disubstituted benzene rings and azacycles for RFs in known molecules, cyclopropanes for RFs in GDB-13s, and single-atom groups for AFs in all databases (Figures S1 and S2). In fact, although the size distribution of the compounds, RFs, and AFs in known molecules extended far beyond 13 atoms (Figures 2c\u20132f), the RFs and AFs up to 13 atoms were sufficient to cover most molecules except for the natural products in COCONUT, which feature many molecules with RFs larger than 13 atoms (Table 1, entry numbers 2\u20134). While fragments shared by the four databases were often structurally simple, those occurring in only one of the four databases analyzed (exclusive fragments, eRF and eAF) were generally more complex, as exemplified by the most frequent cases (Figures S3 and S4).", "sentences": [], "annotations": [], "relations": []}, {"offset": 7125, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_title_caption"}, "text": "Molecule and Fragment Counts in Different\nDatabases", "sentences": [], "annotations": [], "relations": []}, {"offset": 7177, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table frame=\"hsides\" rules=\"groups\" border=\"0\"><colgroup><col align=\"left\"/><col align=\"left\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"right\" char=\".\"/></colgroup><thead><tr><th style=\"border:none;\" align=\"center\">no.<xref rid=\"t1fn1\" ref-type=\"table-fn\">a</xref></th><th style=\"border:none;\" align=\"center\">\u00a0</th><th colspan=\"2\" align=\"center\" char=\".\">ZINC</th><th colspan=\"2\" align=\"center\" char=\".\">PubChem</th><th colspan=\"2\" align=\"center\" char=\".\">COCONUT</th><th colspan=\"2\" align=\"center\" char=\".\">GDB-13s</th></tr></thead><tbody><tr><td style=\"border:none;\" align=\"left\">1</td><td style=\"border:none;\" align=\"left\">cpds<xref rid=\"t1fn2\" ref-type=\"table-fn\">b</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">885\u202f905\u202f524</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">100\u202f852\u202f694</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">401\u202f624</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">99\u202f394\u202f177</td><td style=\"border:none;\" align=\"right\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">2</td><td style=\"border:none;\" align=\"left\">cpds from RF\u00a0\u2264\u00a013<xref rid=\"t1fn3\" ref-type=\"table-fn\">c</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">743\u202f430\u202f899</td><td style=\"border:none;\" align=\"char\" char=\".\">83.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">68\u202f876\u202f892</td><td style=\"border:none;\" align=\"char\" char=\".\">68.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">132\u202f432</td><td style=\"border:none;\" align=\"char\" char=\".\">33.0%</td><td style=\"border:none;\" align=\"char\" char=\".\">99\u202f394\u202f177</td><td style=\"border:none;\" align=\"right\" char=\".\">100%</td></tr><tr><td style=\"border:none;\" align=\"left\">3</td><td style=\"border:none;\" align=\"left\">cpds from AF\u00a0\u2264\u00a013<xref rid=\"t1fn4\" ref-type=\"table-fn\">d</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">818\u202f548\u202f834</td><td style=\"border:none;\" align=\"char\" char=\".\">92.4%</td><td style=\"border:none;\" align=\"char\" char=\".\">94\u202f526\u202f506</td><td style=\"border:none;\" align=\"char\" char=\".\">93.7%</td><td style=\"border:none;\" align=\"char\" char=\".\">357\u202f976</td><td style=\"border:none;\" align=\"char\" char=\".\">89.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">99\u202f394\u202f177</td><td style=\"border:none;\" align=\"right\" char=\".\">100%</td></tr><tr><td style=\"border:none;\" align=\"left\">4</td><td style=\"border:none;\" align=\"left\">cpds from ARF\u00a0\u2264\u00a013<xref rid=\"t1fn5\" ref-type=\"table-fn\">e</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">678\u202f518\u202f591</td><td style=\"border:none;\" align=\"char\" char=\".\">76.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">62\u202f998\u202f179</td><td style=\"border:none;\" align=\"char\" char=\".\">62.5%</td><td style=\"border:none;\" align=\"char\" char=\".\">98\u202f990</td><td style=\"border:none;\" align=\"char\" char=\".\">24.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">99\u202f394\u202f177</td><td style=\"border:none;\" align=\"right\" char=\".\">100%</td></tr><tr><td style=\"border:none;\" align=\"left\">5</td><td style=\"border:none;\" align=\"left\">RF</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f838\u202f201</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">9\u202f037\u202f484</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">115\u202f381</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">28\u202f246\u202f012</td><td style=\"border:none;\" align=\"right\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">6</td><td style=\"border:none;\" align=\"left\">eRF<xref rid=\"t1fn6\" ref-type=\"table-fn\">f</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f165\u202f176</td><td style=\"border:none;\" align=\"char\" char=\".\">76.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">8\u202f139\u202f719</td><td style=\"border:none;\" align=\"char\" char=\".\">90.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">45\u202f448</td><td style=\"border:none;\" align=\"char\" char=\".\">39.4%</td><td style=\"border:none;\" align=\"char\" char=\".\">28\u202f011\u202f035</td><td style=\"border:none;\" align=\"right\" char=\".\">99.2%</td></tr><tr><td style=\"border:none;\" align=\"left\">7</td><td style=\"border:none;\" align=\"left\">RF, singleton<xref rid=\"t1fn7\" ref-type=\"table-fn\">g</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">1\u202f115\u202f630</td><td style=\"border:none;\" align=\"char\" char=\".\">39.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">6\u202f111\u202f177</td><td style=\"border:none;\" align=\"char\" char=\".\">67.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">78\u202f920</td><td style=\"border:none;\" align=\"char\" char=\".\">68.4%</td><td style=\"border:none;\" align=\"char\" char=\".\">23\u202f842\u202f697</td><td style=\"border:none;\" align=\"right\" char=\".\">84.4%</td></tr><tr><td style=\"border:none;\" align=\"left\">8</td><td style=\"border:none;\" align=\"left\">RF\u00a0\u2264\u00a013<xref rid=\"t1fn8\" ref-type=\"table-fn\">h</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">158\u202f576</td><td style=\"border:none;\" align=\"char\" char=\".\">5.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">1\u202f746\u202f923</td><td style=\"border:none;\" align=\"char\" char=\".\">19.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">17\u202f211</td><td style=\"border:none;\" align=\"char\" char=\".\">14.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">28\u202f246\u202f012</td><td style=\"border:none;\" align=\"right\" char=\".\">100%</td></tr><tr><td style=\"border:none;\" align=\"left\">9</td><td style=\"border:none;\" align=\"left\">eRF\u00a0\u2264\u00a013<xref rid=\"t1fn9\" ref-type=\"table-fn\">i</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">17\u202f578</td><td style=\"border:none;\" align=\"char\" char=\".\">0.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">1\u202f333\u202f179</td><td style=\"border:none;\" align=\"char\" char=\".\">14.8%</td><td style=\"border:none;\" align=\"char\" char=\".\">1863</td><td style=\"border:none;\" align=\"char\" char=\".\">1.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">28\u202f011\u202f035</td><td style=\"border:none;\" align=\"right\" char=\".\">99.2%</td></tr><tr><td style=\"border:none;\" align=\"left\">10</td><td style=\"border:none;\" align=\"left\">RF\u00a0\u2264\u00a013, singleton<xref rid=\"t1fn10\" ref-type=\"table-fn\">j</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">58\u202f749</td><td style=\"border:none;\" align=\"char\" char=\".\">2.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">1\u202f048\u202f461</td><td style=\"border:none;\" align=\"char\" char=\".\">11.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">10\u202f244</td><td style=\"border:none;\" align=\"char\" char=\".\">8.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">23\u202f842\u202f697</td><td style=\"border:none;\" align=\"right\" char=\".\">84.4%</td></tr><tr><td style=\"border:none;\" align=\"left\">11</td><td style=\"border:none;\" align=\"left\">AF</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f756\u202f691</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">5\u202f466\u202f187</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">45\u202f816</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f640\u202f023</td><td style=\"border:none;\" align=\"right\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">12</td><td style=\"border:none;\" align=\"left\">eAF<xref rid=\"t1fn6\" ref-type=\"table-fn\">f</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f319\u202f553</td><td style=\"border:none;\" align=\"char\" char=\".\">84.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">4\u202f722\u202f488</td><td style=\"border:none;\" align=\"char\" char=\".\">86.4%</td><td style=\"border:none;\" align=\"char\" char=\".\">18\u202f608</td><td style=\"border:none;\" align=\"char\" char=\".\">40.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f447\u202f627</td><td style=\"border:none;\" align=\"right\" char=\".\">92.7%</td></tr><tr><td style=\"border:none;\" align=\"left\">13</td><td style=\"border:none;\" align=\"left\">AF, singleton<xref rid=\"t1fn7\" ref-type=\"table-fn\">g</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">688\u202f408</td><td style=\"border:none;\" align=\"char\" char=\".\">25.0%</td><td style=\"border:none;\" align=\"char\" char=\".\">4\u202f256\u202f810</td><td style=\"border:none;\" align=\"char\" char=\".\">77.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">34\u202f243</td><td style=\"border:none;\" align=\"char\" char=\".\">74.7%</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f576\u202f927</td><td style=\"border:none;\" align=\"right\" char=\".\">97.6%</td></tr><tr><td style=\"border:none;\" align=\"left\">14</td><td style=\"border:none;\" align=\"left\">AF\u00a0\u2264\u00a013<xref rid=\"t1fn8\" ref-type=\"table-fn\">h</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">338\u202f990</td><td style=\"border:none;\" align=\"char\" char=\".\">12.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f225\u202f960</td><td style=\"border:none;\" align=\"char\" char=\".\">40.7%</td><td style=\"border:none;\" align=\"char\" char=\".\">17\u202f216</td><td style=\"border:none;\" align=\"char\" char=\".\">37.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f640\u202f023</td><td style=\"border:none;\" align=\"right\" char=\".\">100%</td></tr><tr><td style=\"border:none;\" align=\"left\">15</td><td style=\"border:none;\" align=\"left\">eAF\u00a0\u2264\u00a013<xref rid=\"t1fn9\" ref-type=\"table-fn\">i</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">145\u202f340</td><td style=\"border:none;\" align=\"char\" char=\".\">5.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">1\u202f805\u202f294</td><td style=\"border:none;\" align=\"char\" char=\".\">33.0%</td><td style=\"border:none;\" align=\"char\" char=\".\">2131</td><td style=\"border:none;\" align=\"char\" char=\".\">4.7%</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f447\u202f627</td><td style=\"border:none;\" align=\"right\" char=\".\">92.7%</td></tr><tr><td style=\"border:none;\" align=\"left\">16</td><td style=\"border:none;\" align=\"left\">AF\u00a0\u2264\u00a013, singleton<xref rid=\"t1fn10\" ref-type=\"table-fn\">j</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">52\u202f606</td><td style=\"border:none;\" align=\"char\" char=\".\">1.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">1\u202f535\u202f039</td><td style=\"border:none;\" align=\"char\" char=\".\">28.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">9950</td><td style=\"border:none;\" align=\"char\" char=\".\">21.7%</td><td style=\"border:none;\" align=\"char\" char=\".\">2\u202f576\u202f927</td><td style=\"border:none;\" align=\"right\" char=\".\">97.6%</td></tr></tbody></table>\n"}, "text": "no.a\t\u00a0\tZINC\tPubChem\tCOCONUT\tGDB-13s\t \t1\tcpdsb\t885\u202f905\u202f524\t\u00a0\t100\u202f852\u202f694\t\u00a0\t401\u202f624\t\u00a0\t99\u202f394\u202f177\t\u00a0\t \t2\tcpds from RF\u00a0\u2264\u00a013c\t743\u202f430\u202f899\t83.9%\t68\u202f876\u202f892\t68.3%\t132\u202f432\t33.0%\t99\u202f394\u202f177\t100%\t \t3\tcpds from AF\u00a0\u2264\u00a013d\t818\u202f548\u202f834\t92.4%\t94\u202f526\u202f506\t93.7%\t357\u202f976\t89.1%\t99\u202f394\u202f177\t100%\t \t4\tcpds from ARF\u00a0\u2264\u00a013e\t678\u202f518\u202f591\t76.6%\t62\u202f998\u202f179\t62.5%\t98\u202f990\t24.6%\t99\u202f394\u202f177\t100%\t \t5\tRF\t2\u202f838\u202f201\t\u00a0\t9\u202f037\u202f484\t\u00a0\t115\u202f381\t\u00a0\t28\u202f246\u202f012\t\u00a0\t \t6\teRFf\t2\u202f165\u202f176\t76.3%\t8\u202f139\u202f719\t90.1%\t45\u202f448\t39.4%\t28\u202f011\u202f035\t99.2%\t \t7\tRF, singletong\t1\u202f115\u202f630\t39.3%\t6\u202f111\u202f177\t67.6%\t78\u202f920\t68.4%\t23\u202f842\u202f697\t84.4%\t \t8\tRF\u00a0\u2264\u00a013h\t158\u202f576\t5.6%\t1\u202f746\u202f923\t19.3%\t17\u202f211\t14.9%\t28\u202f246\u202f012\t100%\t \t9\teRF\u00a0\u2264\u00a013i\t17\u202f578\t0.6%\t1\u202f333\u202f179\t14.8%\t1863\t1.6%\t28\u202f011\u202f035\t99.2%\t \t10\tRF\u00a0\u2264\u00a013, singletonj\t58\u202f749\t2.1%\t1\u202f048\u202f461\t11.6%\t10\u202f244\t8.9%\t23\u202f842\u202f697\t84.4%\t \t11\tAF\t2\u202f756\u202f691\t\u00a0\t5\u202f466\u202f187\t\u00a0\t45\u202f816\t\u00a0\t2\u202f640\u202f023\t\u00a0\t \t12\teAFf\t2\u202f319\u202f553\t84.1%\t4\u202f722\u202f488\t86.4%\t18\u202f608\t40.6%\t2\u202f447\u202f627\t92.7%\t \t13\tAF, singletong\t688\u202f408\t25.0%\t4\u202f256\u202f810\t77.9%\t34\u202f243\t74.7%\t2\u202f576\u202f927\t97.6%\t \t14\tAF\u00a0\u2264\u00a013h\t338\u202f990\t12.3%\t2\u202f225\u202f960\t40.7%\t17\u202f216\t37.6%\t2\u202f640\u202f023\t100%\t \t15\teAF\u00a0\u2264\u00a013i\t145\u202f340\t5.3%\t1\u202f805\u202f294\t33.0%\t2131\t4.7%\t2\u202f447\u202f627\t92.7%\t \t16\tAF\u00a0\u2264\u00a013, singletonj\t52\u202f606\t1.9%\t1\u202f535\u202f039\t28.1%\t9950\t21.7%\t2\u202f576\u202f927\t97.6%\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 8647, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "no. = entry number.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8667, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "cpds = compounds/molecules.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8695, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "cpds from RF \u2264 13 = molecules\ncovered by ring fragments (RFs) with a heavy atom count (HAC) of up\nto 13.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8802, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "cpds from AF \u2264\n13 = molecules\ncovered by acyclic fragments (AFs) with an HAC of up to 13.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8894, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "cpds from ARF \u2264 13 = molecules\ncovered by both RFs and AFs with an HAC of up to 13.", "sentences": [], "annotations": [], "relations": []}, {"offset": 8980, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "eRF/eAF = exclusive RF/AF, absent\nfrom the other three databases.", "sentences": [], "annotations": [], "relations": []}, {"offset": 9046, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "RF/AF, singleton = RF/AF with only\na single molecule example.", "sentences": [], "annotations": [], "relations": []}, {"offset": 9108, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "RF \u2264 13/AF \u2264 13 =\nRFs/AFs with an HAC of up to 13.", "sentences": [], "annotations": [], "relations": []}, {"offset": 9163, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "eRF \u2264 13/eAR \u2264 13\n= exclusive RFs/AFs with an HAC of up to 13, absent from the other\nthree databases.", "sentences": [], "annotations": [], "relations": []}, {"offset": 9269, "infons": {"file": "tbl1.xml", "id": "tbl1", "section_type": "TABLE", "type": "table_footnote"}, "text": "RF \u2264\n13, singleton/AR \u2264\n13, singleton = RF \u2264 13/AF \u2264 13 with only a single molecule\nexample. RF and AF subcategories are calculated relative to total\nRFs and AFs, respectively.", "sentences": [], "annotations": [], "relations": []}, {"offset": 9454, "infons": {"file": "ci3c01096_0002.jpg", "id": "fig2", "section_type": "FIG", "type": "fig_caption"}, "text": "Frequency distribution of (a) ring fragments (RFs) and (b) acyclic\nfragments (AFs) in ZINC, PubChem, COCONUT, and GDB-13s. Count of compounds\n(Cpds), RFs, exclusive ring fragments (eRFs), AFs, and exclusive acyclic\nfragments (eAFs) in (c) ZINC, (d) PubChem, (e) COCONUT, and (f) GDB-13s\nas a function of the heavy atom count (HAC). The curves of RF and\nAF are depicted thicker than the other curves to help visualize the\ndistribution in the regions with a high overlap.", "sentences": [], "annotations": [], "relations": []}, {"offset": 9924, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "Within the space covered by RFs and AFs of up to 13 atoms, GDB-13s largely outnumbered the known molecules in terms of RFs, resulting in a high percentage of exclusive RFs (99.2% eRFs \u2264 13 atoms, Table 1, entry number 9). Most AFs \u2264 13 atoms in GDB-13s were also exclusive (92.7% eAFs \u2264 13 atoms, Table 1, entry number 15), although the absolute number of AFs in GDB-13s was comparable to the number of AFs in ZINC and smaller than the number of AFs in PubChem. In fact, PubChem, ZINC, and COCONUT also contained many exclusive eRFs \u2264 13 atoms and eAFs \u2264 13 atoms, reflecting that the enumeration of GDB-13s excluded strained rings and certain functional groups and only considered C, N, O, S, and Cl as elements. Nevertheless, the above analysis showed that GDB-13s contained a very large number of both eRFs and eAFs and could therefore serve as a source of novel RFs and AFs to expand the space of known molecules.", "sentences": [], "annotations": [], "relations": []}, {"offset": 10852, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "Comparative Analysis of RFs and AFs in ChEMBL Active and Inactive Molecules", "sentences": [], "annotations": [], "relations": []}, {"offset": 10928, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "Aiming to select novel fragments in GDB-13s by exploiting knowledge on bioactive compounds, we analyzed molecules from the ChEMBL database to test if different RFs and AFs were associated with active or inactive compounds. We selected the 2\u202f136\u202f218 ChEMBL molecules with an HAC \u2264 50, separated them into 560\u202f230 actives (IC50 or EC50 \u2264 10 \u03bcM, ChEMBL_actives) and 1\u202f575\u202f988 inactives (all others, ChEMBL_inactives), and extracted the corresponding RFs and AFs. For each RF and AF, we computed its total occurrence as the number of ChEMBL molecules containing this RF or AF, its relative occurrence in active molecules (% active) and inactive molecules (% inactive), and its activity ratio Rbioactive = (% active)/(% inactive).", "sentences": [], "annotations": [], "relations": []}, {"offset": 11669, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "A volcano scatter plot of the total occurrence of each RF or AF as a function of Rbioactive showed that RFs and AFs spanned a broad range of Rbioactive values and total occurrences (Figures 3a and 3b). The situation was similar when only fragments of up to 13 atoms were analyzed (Figures 3c and 3d). From this analysis, we partitioned ChEMBL fragments according to their Rbioactive values into active (Rbioactive \u2265 4), inactive (Rbioactive \u2264 0.25), or nonpreferential fragments (intermediate values, Rbioactive \u2248 1). While the most frequent fragments were small and nonpreferential, many fragments, including all singletons, occurred exclusively in either the ChEMBL_actives or ChEMBL_inactives subset and were accordingly assigned to either the active (Rbioactive \u2265 4) or inactive (Rbioactive \u2264 0.25) subset, respectively (Table 2). The top 10 most frequent active (Rbioactive \u2265 4) and inactive (Rbioactive \u2264 0.25) RFs and AFs in ChEMBL were all in the size range of GDB-13s. Four of these top 10 active RFs featured halogenated benzene rings, while four of the top 10 inactive RFs were saturated heterocycles (Figure S5). For AFs, fluorine prevailed in four of the top 10 active AFs, while sulfur occurred in four of the top 10 inactive AFs (Figure S6).", "sentences": [], "annotations": [], "relations": []}, {"offset": 12940, "infons": {"file": "ci3c01096_0003.jpg", "id": "fig3", "section_type": "FIG", "type": "fig_caption"}, "text": "Volcano plots\nvisualizing all active and inactive fragments extracted\nfrom ChEMBL. The logarithm value (base 2) of the ratio of the proportion\nof fragments in all active molecules to the proportions of fragments\nin all inactive molecules, namely, log2(% active/% inactive),\nwas plotted on the x-axis, and the total frequency\n(the sum of the occurrences of the fragments in active molecules and\nin inactive molecules) was plotted on the y-axis.\nThe colors of the data points indicate the heavy atom count (HAC)\nrange of the fragments. Occurrences of fragments that only appeared\nin inactive compounds (% active = 0) were displayed vertically in\na straight line at the left end of the plot, while occurrences of\nfragments that only appeared in active compounds (% inactive = 0)\nwere displayed vertically in a straight line at the right end of the\nplot.", "sentences": [], "annotations": [], "relations": []}, {"offset": 13791, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_title_caption"}, "text": "RF/AF Analysis of the ChEMBL_actives\nand ChEMBL_inactives Subsets", "sentences": [], "annotations": [], "relations": []}, {"offset": 13857, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table", "xml": "<?xml version=\"1.0\" encoding=\"UTF-8\"?>\n<table frame=\"hsides\" rules=\"groups\" border=\"0\"><colgroup><col align=\"left\"/><col align=\"left\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/><col align=\"char\" char=\".\"/></colgroup><thead><tr><th style=\"border:none;\" align=\"center\">no.<xref rid=\"t2fn1\" ref-type=\"table-fn\">a</xref></th><th style=\"border:none;\" align=\"center\">\u00a0</th><th colspan=\"2\" align=\"center\" char=\".\">ChEMBL_actives</th><th colspan=\"2\" align=\"center\" char=\".\">ChEMBL_inactives</th><th colspan=\"2\" align=\"center\" char=\".\"><italic>R</italic><sub>bioactive</sub> \u2265\u00a04</th><th colspan=\"2\" align=\"center\" char=\".\"><italic>R</italic><sub>bioactive</sub> \u2248\u00a01</th><th colspan=\"2\" align=\"center\" char=\".\"><italic>R</italic><sub>bioactive</sub> \u2264\u00a00.25</th></tr></thead><tbody><tr><td style=\"border:none;\" align=\"left\">1</td><td style=\"border:none;\" align=\"left\">cpds<xref rid=\"t2fn2\" ref-type=\"table-fn\">b</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">543\u202f971</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">1\u202f575\u202f988</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">2</td><td style=\"border:none;\" align=\"left\">cpds from RF\u00a0\u2264\u00a013<xref rid=\"t2fn3\" ref-type=\"table-fn\">c</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">215\u202f243</td><td style=\"border:none;\" align=\"char\" char=\".\">39.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">870\u202f442</td><td style=\"border:none;\" align=\"char\" char=\".\">55.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">3</td><td style=\"border:none;\" align=\"left\">cpds from AF\u00a0\u2264\u00a013<xref rid=\"t2fn4\" ref-type=\"table-fn\">d</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">523\u202f674</td><td style=\"border:none;\" align=\"char\" char=\".\">96.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">1\u202f509\u202f677</td><td style=\"border:none;\" align=\"char\" char=\".\">95.8%</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">4</td><td style=\"border:none;\" align=\"left\">cpds from ARF\u00a0\u2264\u00a013<xref rid=\"t2fn5\" ref-type=\"table-fn\">e</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">198\u202f367</td><td style=\"border:none;\" align=\"char\" char=\".\">36.5%</td><td style=\"border:none;\" align=\"char\" char=\".\">813\u202f618</td><td style=\"border:none;\" align=\"char\" char=\".\">51.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">5</td><td style=\"border:none;\" align=\"left\">RF</td><td style=\"border:none;\" align=\"char\" char=\".\">145\u202f174</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">300\u202f613</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">116\u202f023</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">25\u202f197</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">266\u202f255</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">6</td><td style=\"border:none;\" align=\"left\">eRF<xref rid=\"t2fn6\" ref-type=\"table-fn\">f</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">106\u202f862</td><td style=\"border:none;\" align=\"char\" char=\".\">73.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">262\u202f301</td><td style=\"border:none;\" align=\"char\" char=\".\">87.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">106\u202f862</td><td style=\"border:none;\" align=\"char\" char=\".\">92.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">0</td><td style=\"border:none;\" align=\"char\" char=\".\">0%</td><td style=\"border:none;\" align=\"char\" char=\".\">262\u202f301</td><td style=\"border:none;\" align=\"char\" char=\".\">98.5%</td></tr><tr><td style=\"border:none;\" align=\"left\">7</td><td style=\"border:none;\" align=\"left\">RF, singleton<xref rid=\"t2fn7\" ref-type=\"table-fn\">g</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">93\u202f023</td><td style=\"border:none;\" align=\"char\" char=\".\">64.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">193\u202f248</td><td style=\"border:none;\" align=\"char\" char=\".\">64.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">78\u202f758</td><td style=\"border:none;\" align=\"char\" char=\".\">67.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">0</td><td style=\"border:none;\" align=\"char\" char=\".\">0%</td><td style=\"border:none;\" align=\"char\" char=\".\">182\u202f620</td><td style=\"border:none;\" align=\"char\" char=\".\">68.6%</td></tr><tr><td style=\"border:none;\" align=\"left\">8</td><td style=\"border:none;\" align=\"left\">RF\u00a0\u2264\u00a013<xref rid=\"t2fn8\" ref-type=\"table-fn\">h</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">28\u202f309</td><td style=\"border:none;\" align=\"char\" char=\".\">19.5%</td><td style=\"border:none;\" align=\"char\" char=\".\">55\u202f143</td><td style=\"border:none;\" align=\"char\" char=\".\">18.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">15\u202f211</td><td style=\"border:none;\" align=\"char\" char=\".\">13.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">10\u202f883</td><td style=\"border:none;\" align=\"char\" char=\".\">43.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">40\u202f930</td><td style=\"border:none;\" align=\"char\" char=\".\">15.4%</td></tr><tr><td style=\"border:none;\" align=\"left\">9</td><td style=\"border:none;\" align=\"left\">eRF\u00a0\u2264\u00a013<xref rid=\"t2fn9\" ref-type=\"table-fn\">i</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">11\u202f881</td><td style=\"border:none;\" align=\"char\" char=\".\">8.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">38\u202f715</td><td style=\"border:none;\" align=\"char\" char=\".\">12.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">11\u202f881</td><td style=\"border:none;\" align=\"char\" char=\".\">10.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">0</td><td style=\"border:none;\" align=\"char\" char=\".\">0%</td><td style=\"border:none;\" align=\"char\" char=\".\">38\u202f715</td><td style=\"border:none;\" align=\"char\" char=\".\">14.5%</td></tr><tr><td style=\"border:none;\" align=\"left\">10</td><td style=\"border:none;\" align=\"left\">RF\u00a0\u2264\u00a013, singleton<xref rid=\"t2fn10\" ref-type=\"table-fn\">j</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">12\u202f260</td><td style=\"border:none;\" align=\"char\" char=\".\">8.5%</td><td style=\"border:none;\" align=\"char\" char=\".\">23\u202f463</td><td style=\"border:none;\" align=\"char\" char=\".\">7.8%</td><td style=\"border:none;\" align=\"char\" char=\".\">7642</td><td style=\"border:none;\" align=\"char\" char=\".\">6.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">0</td><td style=\"border:none;\" align=\"char\" char=\".\">0%</td><td style=\"border:none;\" align=\"char\" char=\".\">20\u202f699</td><td style=\"border:none;\" align=\"char\" char=\".\">7.8%</td></tr><tr><td style=\"border:none;\" align=\"left\">11</td><td style=\"border:none;\" align=\"left\">AF</td><td style=\"border:none;\" align=\"char\" char=\".\">26\u202f482</td><td style=\"border:none;\" align=\"char\" char=\".\">4.7%</td><td style=\"border:none;\" align=\"char\" char=\".\">81\u202f690</td><td style=\"border:none;\" align=\"char\" char=\".\">5.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">16\u202f567</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">8605</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td><td style=\"border:none;\" align=\"char\" char=\".\">71\u202f125</td><td style=\"border:none;\" align=\"char\" char=\".\">\u00a0</td></tr><tr><td style=\"border:none;\" align=\"left\">12</td><td style=\"border:none;\" align=\"left\">eAF<xref rid=\"t2fn6\" ref-type=\"table-fn\">f</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">14\u202f613</td><td style=\"border:none;\" align=\"char\" char=\".\">55.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">69\u202f817</td><td style=\"border:none;\" align=\"char\" char=\".\">85.5%</td><td style=\"border:none;\" align=\"char\" char=\".\">14\u202f613</td><td style=\"border:none;\" align=\"char\" char=\".\">88.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">0</td><td style=\"border:none;\" align=\"char\" char=\".\">0%</td><td style=\"border:none;\" align=\"char\" char=\".\">69\u202f817</td><td style=\"border:none;\" align=\"char\" char=\".\">98.2%</td></tr><tr><td style=\"border:none;\" align=\"left\">13</td><td style=\"border:none;\" align=\"left\">AF, singleton<xref rid=\"t2fn7\" ref-type=\"table-fn\">g</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">15\u202f773</td><td style=\"border:none;\" align=\"char\" char=\".\">59.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">49\u202f745</td><td style=\"border:none;\" align=\"char\" char=\".\">60.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">11\u202f252</td><td style=\"border:none;\" align=\"char\" char=\".\">67.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">0</td><td style=\"border:none;\" align=\"char\" char=\".\">0%</td><td style=\"border:none;\" align=\"char\" char=\".\">46\u202f974</td><td style=\"border:none;\" align=\"char\" char=\".\">66.0%</td></tr><tr><td style=\"border:none;\" align=\"left\">14</td><td style=\"border:none;\" align=\"left\">AF\u00a0\u2264\u00a013<xref rid=\"t2fn8\" ref-type=\"table-fn\">h</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">16\u202f137</td><td style=\"border:none;\" align=\"char\" char=\".\">60.9%</td><td style=\"border:none;\" align=\"char\" char=\".\">45\u202f091</td><td style=\"border:none;\" align=\"char\" char=\".\">55.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">7875</td><td style=\"border:none;\" align=\"char\" char=\".\">47.5%</td><td style=\"border:none;\" align=\"char\" char=\".\">7063</td><td style=\"border:none;\" align=\"char\" char=\".\">82.1%</td><td style=\"border:none;\" align=\"char\" char=\".\">36\u202f498</td><td style=\"border:none;\" align=\"char\" char=\".\">51.3%</td></tr><tr><td style=\"border:none;\" align=\"left\">15</td><td style=\"border:none;\" align=\"left\">eAF\u00a0\u2264\u00a013<xref rid=\"t2fn9\" ref-type=\"table-fn\">i</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">6347</td><td style=\"border:none;\" align=\"char\" char=\".\">24.0%</td><td style=\"border:none;\" align=\"char\" char=\".\">35\u202f301</td><td style=\"border:none;\" align=\"char\" char=\".\">43.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">6347</td><td style=\"border:none;\" align=\"char\" char=\".\">38.3%</td><td style=\"border:none;\" align=\"char\" char=\".\">0</td><td style=\"border:none;\" align=\"char\" char=\".\">0%</td><td style=\"border:none;\" align=\"char\" char=\".\">35\u202f301</td><td style=\"border:none;\" align=\"char\" char=\".\">49.6%</td></tr><tr><td style=\"border:none;\" align=\"left\">16</td><td style=\"border:none;\" align=\"left\">AF\u00a0\u2264\u00a013, singleton<xref rid=\"t2fn10\" ref-type=\"table-fn\">j</xref></td><td style=\"border:none;\" align=\"char\" char=\".\">8008</td><td style=\"border:none;\" align=\"char\" char=\".\">30.2%</td><td style=\"border:none;\" align=\"char\" char=\".\">22\u202f540</td><td style=\"border:none;\" align=\"char\" char=\".\">27.6%</td><td style=\"border:none;\" align=\"char\" char=\".\">4638</td><td style=\"border:none;\" align=\"char\" char=\".\">28.0%</td><td style=\"border:none;\" align=\"char\" char=\".\">0</td><td style=\"border:none;\" align=\"char\" char=\".\">0%</td><td style=\"border:none;\" align=\"char\" char=\".\">20\u202f689</td><td style=\"border:none;\" align=\"char\" char=\".\">29.1%</td></tr></tbody></table>\n"}, "text": "no.a\t\u00a0\tChEMBL_actives\tChEMBL_inactives\tRbioactive \u2265\u00a04\tRbioactive \u2248\u00a01\tRbioactive \u2264\u00a00.25\t \t1\tcpdsb\t543\u202f971\t\u00a0\t1\u202f575\u202f988\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t \t2\tcpds from RF\u00a0\u2264\u00a013c\t215\u202f243\t39.6%\t870\u202f442\t55.2%\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t \t3\tcpds from AF\u00a0\u2264\u00a013d\t523\u202f674\t96.3%\t1\u202f509\u202f677\t95.8%\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t \t4\tcpds from ARF\u00a0\u2264\u00a013e\t198\u202f367\t36.5%\t813\u202f618\t51.6%\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t\u00a0\t \t5\tRF\t145\u202f174\t\u00a0\t300\u202f613\t\u00a0\t116\u202f023\t\u00a0\t25\u202f197\t\u00a0\t266\u202f255\t\u00a0\t \t6\teRFf\t106\u202f862\t73.6%\t262\u202f301\t87.3%\t106\u202f862\t92.1%\t0\t0%\t262\u202f301\t98.5%\t \t7\tRF, singletong\t93\u202f023\t64.1%\t193\u202f248\t64.3%\t78\u202f758\t67.9%\t0\t0%\t182\u202f620\t68.6%\t \t8\tRF\u00a0\u2264\u00a013h\t28\u202f309\t19.5%\t55\u202f143\t18.3%\t15\u202f211\t13.1%\t10\u202f883\t43.2%\t40\u202f930\t15.4%\t \t9\teRF\u00a0\u2264\u00a013i\t11\u202f881\t8.2%\t38\u202f715\t12.9%\t11\u202f881\t10.2%\t0\t0%\t38\u202f715\t14.5%\t \t10\tRF\u00a0\u2264\u00a013, singletonj\t12\u202f260\t8.5%\t23\u202f463\t7.8%\t7642\t6.6%\t0\t0%\t20\u202f699\t7.8%\t \t11\tAF\t26\u202f482\t4.7%\t81\u202f690\t5.2%\t16\u202f567\t\u00a0\t8605\t\u00a0\t71\u202f125\t\u00a0\t \t12\teAFf\t14\u202f613\t55.2%\t69\u202f817\t85.5%\t14\u202f613\t88.2%\t0\t0%\t69\u202f817\t98.2%\t \t13\tAF, singletong\t15\u202f773\t59.6%\t49\u202f745\t60.9%\t11\u202f252\t67.9%\t0\t0%\t46\u202f974\t66.0%\t \t14\tAF\u00a0\u2264\u00a013h\t16\u202f137\t60.9%\t45\u202f091\t55.2%\t7875\t47.5%\t7063\t82.1%\t36\u202f498\t51.3%\t \t15\teAF\u00a0\u2264\u00a013i\t6347\t24.0%\t35\u202f301\t43.2%\t6347\t38.3%\t0\t0%\t35\u202f301\t49.6%\t \t16\tAF\u00a0\u2264\u00a013, singletonj\t8008\t30.2%\t22\u202f540\t27.6%\t4638\t28.0%\t0\t0%\t20\u202f689\t29.1%\t \t", "sentences": [], "annotations": [], "relations": []}, {"offset": 15221, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "no. = entry number.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15241, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "cpds = compounds/molecules.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15269, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "cpds from RF \u2264 13 = molecules\ncovered by ring fragments (RFs) with a heavy atom count (HAC) of up\nto 13.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15376, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "cpds from AF \u2264\n13 = molecules\ncovered by acyclic fragments (AFs) with an HAC of up to 13.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15468, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "cpds from ARF \u2264 13 = molecules\ncovered by both RFs and AFs with an HAC of up to 13.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15554, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "eRF/eAF = exclusive RF/AF, absent\nfrom the other three databases.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15620, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "RF/AF, singleton = RF/AF with only\na single molecule example.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15682, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "RF \u2264 13/AF \u2264 13 =\nRF/AF with an HAC of up to 13.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15735, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "eRF \u2264 13/eAR \u2264 13\n= exclusive RFs/AFs with an HAC of up to 13, absent from the other\nthree databases.", "sentences": [], "annotations": [], "relations": []}, {"offset": 15841, "infons": {"file": "tbl2.xml", "id": "tbl2", "section_type": "TABLE", "type": "table_footnote"}, "text": "RF \u2264\n13, singleton/AR \u2264\n13, singleton = RF \u2264 13/AF \u2264 13 with only a single molecule\nexample. The RF and AF subcategories are calculated relative to total\nRFs and AFs, respectively.", "sentences": [], "annotations": [], "relations": []}, {"offset": 16030, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "While many RFs and AFs occurred preferentially in either the ChEMBL_active or ChEMBL_inactive molecules, these fragments did not differ strongly from each other or from RFs and AFs in known molecules (PubChem, ZINC, and COCONUT) in terms of overall structural features. Indeed, the different data sets of known molecules had quite similar property profiles for RFs of up to 13 atoms in terms of the number of rings, the largest ring size, and the number of acyclic atoms and heteroatoms (Figures 4a\u20134d). Similarly, AFs of up to 13 atoms in these data sets had comparable property profiles concerning the number of quaternary centers, triple bonds, heteroatoms, and terminal atoms (Figures S7a\u2013S7d).", "sentences": [], "annotations": [], "relations": []}, {"offset": 16733, "infons": {"file": "ci3c01096_0004.jpg", "id": "fig4", "section_type": "FIG", "type": "fig_caption"}, "text": "Frequency histograms\nof ring fragments (RFs) from the various databases\nand subsets for (a) the number of rings, (b) the largest ring size,\n(c) the number of acyclic atoms, (d) the number of heteroatoms, (e)\nthe synthetic accessibility score (SAscore), and (f) the natural product\nlikeness score (NPscore).", "sentences": [], "annotations": [], "relations": []}, {"offset": 17040, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "On the other hand, the property profiles of GDB-13s RFs and AFs were clearly different from those of known molecules. For instance, RFs from GDB-13s had a broader distribution in terms of the number of rings and the largest ring size and fewer heteroatoms than the different RF data sets of known molecules. Furthermore, the GDB-13s AFs stood out with a larger number of triple bonds and terminal atoms compared to the AF data sets of known molecules. These differences probably explained the less favorable synthetic accessibility score (SAscore) of the GDB-13s RFs and AFs (Figures 4e and S7e). Indeed, the SAscore is based on the presence of substructures frequently found in known molecules. Note that the GDB-13s RFs and AFs had relatively high natural product likeness scores (NPscores), comparable to those of the COCONUT molecules (Figures 4f and S7f). The high NPscores of the GDB-13s RFs and AFs probably reflect the high percentage of non-aromatic, stereochemically complex structures in GDB-13s since the NPscore assigns higher values for the presence of such structural features.", "sentences": [], "annotations": [], "relations": []}, {"offset": 18133, "infons": {"section_type": "RESULTS", "type": "title_2"}, "text": "Bioactivity-Guided Selection of RFs and AFs in GDB-13s", "sentences": [], "annotations": [], "relations": []}, {"offset": 18188, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "The analysis presented above suggested two possible approaches to select RFs and AFs from GDB-13s for drug design. First, the narrower structural parameter ranges covered by RFs and AFs from known molecules, active or inactive, which correlated with their more favorable SAscores compared to the GDB-13s RFs and AFs, indicated to select GDB-13s fragments with limited structural complexity, which would certainly help with a possible synthesis. Following up on this idea, we selected a subset of GDB-13s RFs and AFs by constraining the structural parameters closer to known molecules but considering only those exclusive to GDB-13s to ensure novelty. To our delight, this selection resulted in a sizable number of GDB-13s fragments. Indeed, we obtained 960\u202f587 GDB-13s eRFs with up to two rings, a ring size up to seven, up to three heteroatoms, and three acyclic atoms, named RFset1. For the selection of AFs from GDB-13s, we obtained 462\u202f439 GDB-13s eAFs without any quaternary center and up to one triple bond, up to four heteroatoms, and up to four terminal atoms, named AFset1.", "sentences": [], "annotations": [], "relations": []}, {"offset": 19275, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "In a second, narrower selection, we assumed that ChEMBL-derived RFs and AFs in the Rbioactive \u2265 4 value range (defined as active fragments) reflected privileged structural types, while those in the Rbioactive \u2264 0.25 value range (defined as inactive fragments) marked undesirable structural types in terms of possible bioactivities. To expand the scope of the ChEMBL active fragments, we retrieved all GDB-13s RFs and AFs within a Jaccard distance dJ \u2264 0.6 of any of the ChEMBL active fragments, using the MAP4 fingerprint as a similarity measure. In this manner, we obtained 97\u202f664 RFs and 43\u202f704 AFs, from which we removed the 25\u202f162 RFs and 15\u202f484 AFs found within dJ \u2264 0.6 of any inactive fragments, leaving 72\u202f502 RFs, named RFset2, and 28\u202f220 AFs, named AFset2, as bioactive-like fragments from GDB-13s. In these sets, many fragments were also exclusive to GDB-13s, ensuring novelty (51\u202f303 eRFs, 70.8%; 17\u202f620 eAFs, 62.4%).", "sentences": [], "annotations": [], "relations": []}, {"offset": 20229, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "The property profiles of RFset1 and AFset1, which both resulted from constraining structural parameters, remained substantially different from those of known molecules because the frequency peaked at the highest parameter value selected. This distribution reflects the combinatorial enumeration used to generate GDB-13s, which provides many more possible molecules at the largest values of structural parameters. Therefore, the SAscore remained less favorable and the NPscore relatively high in both sets. On the other hand, the property profiles of RFset2 and AFset2, selected by substructure similarity to ChEMBL bioactive fragments, were like those of known molecules, reflecting the structural similarity selection used to compose these sets (Figures 4a\u20134d and S7a\u2013S7d). RFset2 and AFset2 also displayed lower SAscore and NPscore values than the full sets of GDB-13s RFs and AFs, indicating that they were generally less complex and closer to the RFs and AFs from known molecules (Figures 4e, 4f, S7e, and S7f).", "sentences": [], "annotations": [], "relations": []}, {"offset": 21249, "infons": {"section_type": "RESULTS", "type": "paragraph"}, "text": "To gain a detailed insight into the bioactivity-selected subset of GDB-13s RFs and AFs, we computed interactive TMAPs (tree maps) using the MinHashed fingerprint MAP4 as a similarity measure (Figure 5). These interactive TMAPs allow one to browse through the two databases and search for interesting RFs and AFs using various color-coded properties as guides. To illustrate the available options, we searched for novel analogues of the three most frequent active (Rbioactive \u2265 4) RFs in ChEMBL, one of which occurs in the kinase inhibitor drug gefitinib, revealing potentially interesting analogues (Figure 6). More interesting GDB-13s eRFs are exemplified as analogues of triquinazine, an eRF from GDB-13s previously used as a scaffold for a Janus kinase inhibitor analogue of the known drug tofacitinib. In principle, the same selection can also be made with the GDB-13s analogues of AFs, as exemplified for the most frequent active (Rbioactive \u2265 4) AFs from ChEMBL (Figure S8). In this case, however, the selection of interesting AFs is less obvious since the chemistry of AFs highly depends on their connection to RFs.", "sentences": [], "annotations": [], "relations": []}, {"offset": 22376, "infons": {"file": "ci3c01096_0005.jpg", "id": "fig5", "section_type": "FIG", "type": "fig_caption"}, "text": "Tree map (TMAP) visualization of (a) the 1\u202f042\u202f610\nring fragments (RFs) from RFset1, RFset2, and ChEMBL; (b) the top\n10\u202f000 RFs in ZINC, PubChem, COCONUT, and GDB-13s; (c) the\n533\u202f153 acyclic fragments (AFs) from AFset1, AFset2, and ChEMBL;\nand (d) the top 10\u202f000 AFs in ZINC, PubChem, COCONUT, and GDB-13s,\ncolor-coded by the source data sets, the synthetic accessibility score\n(SAscore), and different properties. An interactive version of the\nTMAPs is accessible at  (MAP4_fused_GDB-13s_RFset1_RFset2_and_ChEMBL; MAP4_4databases_top10k_RF;\nMAP4_fused_GDB-13s_AFset1_AFset2_and_ChEMBL; MAP4_4databases_top10k_AF).", "sentences": [], "annotations": [], "relations": []}, {"offset": 23002, "infons": {"file": "ci3c01096_0006.jpg", "id": "fig6", "section_type": "FIG", "type": "fig_caption"}, "text": "Analogues of highly active ChEMBL ring fragments (RFs)\nand triquinazine\nfound in the subsets of GDB-13s (RFset1/RFset2). The\ntotal occurrences of the ChEMBL RFs, or the MAP4 fingerprint jaccard\ndistances between the analogues from GDB-13s and the corresponding\nChEMBL Active RF, are indicated below the structures.", "sentences": [], "annotations": [], "relations": []}, {"offset": 23317, "infons": {"section_type": "CONCL", "type": "title_1"}, "text": "Conclusion", "sentences": [], "annotations": [], "relations": []}, {"offset": 23328, "infons": {"section_type": "CONCL", "type": "paragraph"}, "text": "In summary, deconstructing known molecules from the ZINC and PubChem databases and natural products from the COCONUT database to form fragments (RFs and AFs) showed that these molecules mostly consist of RFs and AFs of 13 atoms or less. A comparative analysis of the database GDB-13s, which lists 99 million possible molecules of up to 13 atoms, showed that over 99% of the 28 million RFs and 93% of the 2.6 million AFs in GDB-13s are absent from public databases and are therefore exclusive and, in principle, novel. Furthermore, by analyzing the ChEMBL database, we found that certain RFs and AFs occur more frequently in known active vs inactive molecules. Analyzing the properties of active RFs and AFs in ChEMBL to define property and similarity ranges then allowed us to extract one million RFs and half a million AFs from GDB-13s with ChEMBL-active-like features. These ChEMBL-active-like RFs and AFs from GDB-13s are structurally relatively simple and have favorable SAscores and therefore represent attractive targets for synthesizing new fragments with favorable properties for drug design.", "sentences": [], "annotations": [], "relations": []}, {"offset": 24429, "infons": {"section_type": "METHODS", "type": "title_1"}, "text": "Methods", "sentences": [], "annotations": [], "relations": []}, {"offset": 24437, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "Extracting RFs and AFs from Molecules", "sentences": [], "annotations": [], "relations": []}, {"offset": 24475, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "The RFs and AFs were obtained from molecules by processing their SMILES using RDkit as follows (Figure 1). RFs: break all bonds between any two acyclic atoms and remove all acyclic atoms not directly attached to the rings. Acyclic atoms directly connected to more than one ring system are disconnected and reattached to each ring system separately. AFs: break all bonds between the cyclic and acyclic atoms and remove all cyclic atoms.", "sentences": [], "annotations": [], "relations": []}, {"offset": 24911, "infons": {"section_type": "METHODS", "type": "title_2"}, "text": "TMAPs", "sentences": [], "annotations": [], "relations": []}, {"offset": 24917, "infons": {"section_type": "METHODS", "type": "paragraph"}, "text": "Tree maps (TMAPs) were generated by specifying standard parameters using the MAP4 fingerprint (MinHashed atom-pair fingerprint up to a diameter of four bonds). MAP4 fingerprints were computed with dimensions of 256.", "sentences": [], "annotations": [], "relations": []}, {"offset": 25133, "infons": {"section_type": "SUPPL", "type": "title"}, "text": "Data Availability Statement", "sentences": [], "annotations": [], "relations": []}, {"offset": 25161, "infons": {"section_type": "SUPPL", "type": "paragraph"}, "text": "GDB-13 (970 million molecules of up to 13 atoms enumerated from graphs under ring strain and functional group restriction criteria, as described earlier) and GDB-13s (a 99 million molecule subset of GDB-13 with additional functional group restrictions, as described earlier) are hosted on the open-access repository Zenodo and can be downloaded free of charge at . All the molecules are stored in a dearomatized, canonized SMILES format and compressed as a GNU zip archive. The ZINC data used in this study were the February 2022 version (). The October 2021 version of the PubChem data was first downloaded from the NCBI (National Center for Biotechnology Information), NIH (National Institutes of Health) via an FTP server (). Then the compounds with HACs not greater than 50 were extracted to build the PubChem database. The COCONUT data adopted in this study were the February 2021 version (). ChEMBL_active and ChEMBL_inactive data sets were extracted from ChEMBL31 (). The Molecule Breakdown Model has been made freely available and is under the MIT license. It was distributed in a GitHub repository upon publication of this manuscript: .", "sentences": [], "annotations": [], "relations": []}, {"offset": 26307, "infons": {"section_type": "SUPPL", "type": "title"}, "text": "Supporting Information Available", "sentences": [], "annotations": [], "relations": []}, {"offset": 26340, "infons": {"section_type": "SUPPL", "type": "paragraph"}, "text": "Top 10 most populated RFs/AFs in GDB-13s, ZINC, PubChem, and COCONUT; top 20 most frequent RFs shared by the different databases; top 10 eRFs in the different databases; top 10 most frequent RFs and AFs in the active and inactive ChEMBL subsets; frequency histograms of the AFs from the various databases and subsets for the number of quaternary centers, number of triple bonds, number of heteroatoms, number of terminal atoms, SAscore, and NPscore; and analogues of highly active ChEMBL AFs found in GDB-13s AFset1/AFset2 (PDF)", "sentences": [], "annotations": [], "relations": []}, {"offset": 26869, "infons": {"section_type": "SUPPL", "type": "paragraph"}, "text": "The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.jcim.3c01096.", "sentences": [], "annotations": [], "relations": []}, {"offset": 26978, "infons": {"section_type": "SUPPL", "type": "title_1"}, "text": "Supplementary Material", "sentences": [], "annotations": [], "relations": []}, {"offset": 27001, "infons": {"section_type": "AUTH_CONT", "type": "title"}, "text": "Author Contributions", "sentences": [], "annotations": [], "relations": []}, {"offset": 27022, "infons": {"section_type": "AUTH_CONT", "type": "paragraph"}, "text": "Y.B. designed and realized the study and wrote the paper. J.-L.R. codesigned and supervised the study and wrote the paper.", "sentences": [], "annotations": [], "relations": []}, {"offset": 27145, "infons": {"section_type": "AUTH_CONT", "type": "paragraph"}, "text": "This work was funded by the Swiss National Science Foundation, Grant 200020_207976.", "sentences": [], "annotations": [], "relations": []}, {"offset": 27229, "infons": {"section_type": "AUTH_CONT", "type": "paragraph"}, "text": "The authors declare no competing financial interest.", "sentences": [], "annotations": [], "relations": []}, {"offset": 27282, "infons": {"section_type": "REF", "type": "title"}, "text": "References", "sentences": [], "annotations": [], "relations": []}, {"offset": 27293, "infons": {"fpage": "D1102", "lpage": "D1109", "name_0": "surname:Kim;given-names:S.", "name_1": "surname:Chen;given-names:J.", "name_10": "surname:Zaslavsky;given-names:L.", "name_11": "surname:Zhang;given-names:J.", "name_12": "surname:Bolton;given-names:E. E.", "name_2": "surname:Cheng;given-names:T.", "name_3": "surname:Gindulyte;given-names:A.", "name_4": "surname:He;given-names:J.", "name_5": "surname:He;given-names:S.", "name_6": "surname:Li;given-names:Q.", "name_7": "surname:Shoemaker;given-names:B. A.", "name_8": "surname:Thiessen;given-names:P. A.", "name_9": "surname:Yu;given-names:B.", "pub-id_doi": "10.1093/nar/gky1033", "pub-id_pmid": "30371825", "section_type": "REF", "source": "Nucleic Acids Res.", "type": "ref", "volume": "47", "year": "2019"}, "text": "PubChem 2019 Update: Improved Access to Chemical Data", "sentences": [], "annotations": [], "relations": []}, {"offset": 27347, "infons": {"fpage": "D930", "lpage": "D940", "name_0": "surname:Mendez;given-names:D.", "name_1": "surname:Gaulton;given-names:A.", "name_10": "surname:Gordillo-Mara\u00f1\u00f3n;given-names:M.", "name_11": "surname:Hunter;given-names:F.", "name_12": "surname:Junco;given-names:L.", "name_13": "surname:Mugumbate;given-names:G.", "name_14": "surname:Rodriguez-Lopez;given-names:M.", "name_15": "surname:Atkinson;given-names:F.", "name_16": "surname:Bosc;given-names:N.", "name_17": "surname:Radoux;given-names:C. J.", "name_18": "surname:Segura-Cabrera;given-names:A.", "name_19": "surname:Hersey;given-names:A.", "name_2": "surname:Bento;given-names:A. P.", "name_20": "surname:Leach;given-names:A. R.", "name_3": "surname:Chambers;given-names:J.", "name_4": "surname:De Veij;given-names:M.", "name_5": "surname:F\u00e9lix;given-names:E.", "name_6": "surname:Magari\u00f1os;given-names:M. P.", "name_7": "surname:Mosquera;given-names:J. F.", "name_8": "surname:Mutowo;given-names:P.", "name_9": "surname:Nowotka;given-names:M.", "pub-id_doi": "10.1093/nar/gky1075", "pub-id_pmid": "30398643", "section_type": "REF", "source": "Nucleic\nAcids Res.", "type": "ref", "volume": "47", "year": "2019"}, "text": "ChEMBL: Towards Direct Deposition of Bioassay Data", "sentences": [], "annotations": [], "relations": []}, {"offset": 27398, "infons": {"fpage": "5845", "lpage": "5859", "name_0": "surname:Taylor;given-names:R. D.", "name_1": "surname:MacCoss;given-names:M.", "name_2": "surname:Lawson;given-names:A. D. G.", "pub-id_doi": "10.1021/jm4017625", "pub-id_pmid": "24471928", "section_type": "REF", "source": "J. Med. Chem.", "type": "ref", "volume": "57", "year": "2014"}, "text": "Rings in Drugs", "sentences": [], "annotations": [], "relations": []}, {"offset": 27413, "infons": {"fpage": "10026", "lpage": "10043", "name_0": "surname:Ivanenkov;given-names:Y. A.", "name_1": "surname:Zagribelnyy;given-names:B. A.", "name_2": "surname:Aladinskiy;given-names:V. A.", "pub-id_doi": "10.1021/acs.jmedchem.9b00004", "pub-id_pmid": "31188596", "section_type": "REF", "source": "J. Med. Chem.", "type": "ref", "volume": "62", "year": "2019"}, "text": "Are We Opening the Door to a New Era of Medicinal Chemistry or Being Collapsed to a Chemical Singularity?", "sentences": [], "annotations": [], "relations": []}, {"offset": 27519, "infons": {"fpage": "636", "lpage": "679", "name_0": "surname:Krieger;given-names:J.", "name_1": "surname:Li;given-names:D.", "name_2": "surname:Papanikolaou;given-names:D.", "pub-id_doi": "10.1093/rfs/hhab024", "section_type": "REF", "source": "Rev. Financ. Stud.", "type": "ref", "volume": "35", "year": "2022"}, "text": "Missing Novelty in Drug Development*", "sentences": [], "annotations": [], "relations": []}, {"offset": 27556, "infons": {"fpage": "2339", "lpage": "2381", "name_0": "surname:Bhutani;given-names:P.", "name_1": "surname:Joshi;given-names:G.", "name_2": "surname:Raja;given-names:N.", "name_3": "surname:Bachhav;given-names:N.", "name_4": "surname:Rajanna;given-names:P. K.", "name_5": "surname:Bhutani;given-names:H.", "name_6": "surname:Paul;given-names:A. T.", "name_7": "surname:Kumar;given-names:R. U.S.", "pub-id_doi": "10.1021/acs.jmedchem.0c01786", "pub-id_pmid": "33617716", "section_type": "REF", "source": "J.\nMed. Chem.", "type": "ref", "volume": "64", "year": "2021"}, "text": "FDA Approved Drugs from 2015\u2013June 2020: A Perspective", "sentences": [], "annotations": [], "relations": []}, {"offset": 27612, "infons": {"fpage": "1148", "lpage": "1156", "name_0": "surname:Hoffmann;given-names:T.", "name_1": "surname:Gastreich;given-names:M.", "pub-id_doi": "10.1016/j.drudis.2019.02.013", "pub-id_pmid": "30851414", "section_type": "REF", "source": "Drug\nDiscovery Today", "type": "ref", "volume": "24", "year": "2019"}, "text": "The next Level in Chemical Space Navigation: Going Far beyond Enumerable Compound Libraries", "sentences": [], "annotations": [], "relations": []}, {"offset": 27704, "infons": {"fpage": "2021", "lpage": "2034", "name_0": "surname:Warr;given-names:W. A.", "name_1": "surname:Nicklaus;given-names:M. C.", "name_2": "surname:Nicolaou;given-names:C. A.", "name_3": "surname:Rarey;given-names:M.", "pub-id_doi": "10.1021/acs.jcim.2c00224", "pub-id_pmid": "35421301", "section_type": "REF", "source": "J.\nChem. Inf. Model.", "type": "ref", "volume": "62", "year": "2022"}, "text": "Exploration of Ultralarge Compound Collections for Drug Discovery", "sentences": [], "annotations": [], "relations": []}, {"offset": 27770, "infons": {"fpage": "6065", "lpage": "6073", "name_0": "surname:Irwin;given-names:J. J.", "name_1": "surname:Tang;given-names:K. G.", "name_2": "surname:Young;given-names:J.", "name_3": "surname:Dandarchuluun;given-names:C.", "name_4": "surname:Wong;given-names:B. R.", "name_5": "surname:Khurelbaatar;given-names:M.", "name_6": "surname:Moroz;given-names:Y. S.", "name_7": "surname:Mayfield;given-names:J.", "name_8": "surname:Sayle;given-names:R. A.", "pub-id_doi": "10.1021/acs.jcim.0c00675", "pub-id_pmid": "33118813", "section_type": "REF", "source": "J. Chem. Inf. Model.", "type": "ref", "volume": "60", "year": "2020"}, "text": "ZINC20-A Free Ultralarge-Scale Chemical Database for Ligand Discovery", "sentences": [], "annotations": [], "relations": []}, {"offset": 27840, "infons": {"elocation-id": "101681", "name_0": "surname:Grygorenko;given-names:O. O.", "name_1": "surname:Radchenko;given-names:D. S.", "name_2": "surname:Dziuba;given-names:I.", "name_3": "surname:Chuprina;given-names:A.", "name_4": "surname:Gubina;given-names:K. E.", "name_5": "surname:Moroz;given-names:Y. S.", "pub-id_doi": "10.1016/j.isci.2020.101681", "pub-id_pmid": "33145486", "section_type": "REF", "source": "iScience", "type": "ref", "volume": "23", "year": "2020"}, "text": "Generating Multibillion Chemical Space of Readily Accessible Screening Compounds", "sentences": [], "annotations": [], "relations": []}, {"offset": 27921, "infons": {"fpage": "673", "lpage": "685", "name_0": "surname:Sadybekov;given-names:A. V.", "name_1": "surname:Katritch;given-names:V.", "pub-id_doi": "10.1038/s41586-023-05905-z", "pub-id_pmid": "37100941", "section_type": "REF", "source": "Nature", "type": "ref", "volume": "616", "year": "2023"}, "text": "Computational Approaches Streamlining Drug Discovery", "sentences": [], "annotations": [], "relations": []}, {"offset": 27974, "infons": {"fpage": "4676", "lpage": "4688", "name_0": "surname:Dickson;given-names:P.", "name_1": "surname:Kodadek;given-names:T.", "pub-id_doi": "10.1039/C9OB00581A", "pub-id_pmid": "31017595", "section_type": "REF", "source": "Org. Biomol. Chem.", "type": "ref", "volume": "17", "year": "2019"}, "text": "Chemical Composition of DNA-Encoded Libraries, Past Present and Future", "sentences": [], "annotations": [], "relations": []}, {"offset": 28045, "infons": {"fpage": "1265", "lpage": "1279", "name_0": "surname:Gironda-Mart\u00ednez;given-names:A.", "name_1": "surname:Donckele;given-names:E. J.", "name_2": "surname:Samain;given-names:F.", "name_3": "surname:Neri;given-names:D.", "pub-id_doi": "10.1021/acsptsci.1c00118", "pub-id_pmid": "34423264", "section_type": "REF", "source": "ACS Pharmacol. Transl. Sci.", "type": "ref", "volume": "4", "year": "2021"}, "text": "DNA-Encoded Chemical Libraries: A Comprehensive Review with Succesful Stories and Future Challenges", "sentences": [], "annotations": [], "relations": []}, {"offset": 28145, "infons": {"fpage": "699", "lpage": "722", "name_0": "surname:Peterson;given-names:A. A.", "name_1": "surname:Liu;given-names:D. R.", "pub-id_doi": "10.1038/s41573-023-00713-6", "pub-id_pmid": "37328653", "section_type": "REF", "source": "Nat. Rev. Drug\nDiscovery.", "type": "ref", "year": "2023"}, "text": "Small-Molecule Discovery through DNA-Encoded Libraries", "sentences": [], "annotations": [], "relations": []}, {"offset": 28200, "infons": {"elocation-id": "e202215542", "name_0": "surname:Dockerill;given-names:M.", "name_1": "surname:Winssinger;given-names:N.", "pub-id_doi": "10.1002/ange.202215542", "section_type": "REF", "source": "Angew. Chem.", "type": "ref", "volume": "135", "year": "2023"}, "text": "DNA-Encoded Libraries: Towards Harnessing Their Full Power with Darwinian Evolution", "sentences": [], "annotations": [], "relations": []}, {"offset": 28284, "infons": {"fpage": "24", "lpage": "29", "name_0": "surname:Zorzi;given-names:A.", "name_1": "surname:Deyle;given-names:K.", "name_2": "surname:Heinis;given-names:C.", "pub-id_doi": "10.1016/j.cbpa.2017.02.006", "pub-id_pmid": "28249193", "section_type": "REF", "source": "Curr. Opin Chem. Biol.", "type": "ref", "volume": "38", "year": "2017"}, "text": "Cyclic Peptide Therapeutics: Past, Present and Future", "sentences": [], "annotations": [], "relations": []}, {"offset": 28338, "infons": {"fpage": "1953", "lpage": "1965", "name_0": "surname:Saha;given-names:A.", "name_1": "surname:Suga;given-names:H.", "name_2": "surname:Brik;given-names:A.", "pub-id_doi": "10.1021/acs.accounts.3c00178", "pub-id_pmid": "37312234", "section_type": "REF", "source": "Acc. Chem. Res.", "type": "ref", "volume": "56", "year": "2023"}, "text": "Combining Chemical Protein Synthesis and Random Nonstandard Peptides Integrated Discovery for Modulating Biological Processes", "sentences": [], "annotations": [], "relations": []}, {"offset": 28464, "infons": {"fpage": "23", "lpage": "29", "name_0": "surname:Poongavanam;given-names:V.", "name_1": "surname:Doak;given-names:B. C.", "name_2": "surname:Kihlberg;given-names:J.", "pub-id_doi": "10.1016/j.cbpa.2018.05.010", "pub-id_pmid": "29803972", "section_type": "REF", "source": "Curr. Opin Chem. Biol.", "type": "ref", "volume": "44", "year": "2018"}, "text": "Opportunities and Guidelines for Discovery of Orally Absorbed Drugs in beyond Rule of 5 Space", "sentences": [], "annotations": [], "relations": []}, {"offset": 28558, "infons": {"fpage": "3", "lpage": "4", "name_0": "surname:Hartung;given-names:I. V.", "name_1": "surname:Huck;given-names:B. R.", "name_2": "surname:Crespo;given-names:A.", "pub-id_doi": "10.1038/s41570-022-00451-0", "pub-id_pmid": "37117823", "section_type": "REF", "source": "Nat. Rev. Chem.", "type": "ref", "volume": "7", "year": "2023"}, "text": "Rules Were Made to Be Broken", "sentences": [], "annotations": [], "relations": []}, {"offset": 28587, "infons": {"fpage": "8732", "lpage": "8733", "name_0": "surname:Blum;given-names:L. C.", "name_1": "surname:Reymond;given-names:J.-L.", "pub-id_doi": "10.1021/ja902302h", "pub-id_pmid": "19505099", "section_type": "REF", "source": "J.\nAm. Chem. Soc.", "type": "ref", "volume": "131", "year": "2009"}, "text": "970 Million Druglike Small Molecules for Virtual Screening in the Chemical Universe Database GDB-13", "sentences": [], "annotations": [], "relations": []}, {"offset": 28687, "infons": {"fpage": "717", "lpage": "733", "name_0": "surname:Reymond;given-names:J.-L.", "name_1": "surname:Ruddigkeit;given-names:L.", "name_2": "surname:Blum;given-names:L.", "name_3": "surname:van Deursen;given-names:R.", "pub-id_doi": "10.1002/wcms.1104", "section_type": "REF", "source": "WIREs Comput. Mol. Sci.", "type": "ref", "volume": "2", "year": "2012"}, "text": "The Enumeration of Chemical Space", "sentences": [], "annotations": [], "relations": []}, {"offset": 28721, "infons": {"fpage": "241", "lpage": "241", "name_0": "surname:Meier;given-names:K.", "name_1": "surname:B\u00fchlmann;given-names:S.", "name_2": "surname:Ar\u00fas-Pous;given-names:J.", "name_3": "surname:Reymond;given-names:J.-L.", "pub-id_doi": "10.2533/chimia.2020.241", "pub-id_pmid": "32331540", "section_type": "REF", "source": "CHIMIA", "type": "ref", "volume": "74", "year": "2020"}, "text": "The Generated Databases (GDBs) as a Source of 3D-Shaped Building Blocks for Use in Medicinal Chemistry and Drug Discovery", "sentences": [], "annotations": [], "relations": []}, {"offset": 28843, "infons": {"fpage": "445", "lpage": "447", "name_0": "surname:Mullard;given-names:A.", "pub-id_doi": "10.1038/549445a", "pub-id_pmid": "28959982", "section_type": "REF", "source": "Nature", "type": "ref", "volume": "549", "year": "2017"}, "text": "The Drug-Maker\u2019s Guide to the Galaxy", "sentences": [], "annotations": [], "relations": []}, {"offset": 28882, "infons": {"fpage": "2887", "lpage": "2893", "name_0": "surname:Bemis;given-names:G. W.", "name_1": "surname:Murcko;given-names:M. A.", "pub-id_doi": "10.1021/jm9602928", "pub-id_pmid": "8709122", "section_type": "REF", "source": "J. Med.\nChem.", "type": "ref", "volume": "39", "year": "1996"}, "text": "The Properties of Known Drugs. 1. Molecular Frameworks", "sentences": [], "annotations": [], "relations": []}, {"offset": 28937, "infons": {"fpage": "484", "lpage": "492", "name_0": "surname:Buehler;given-names:Y.", "name_1": "surname:Reymond;given-names:J.-L.", "pub-id_doi": "10.1021/acs.jcim.2c01107", "pub-id_pmid": "36533982", "section_type": "REF", "source": "J. Chem. Inf. Model.", "type": "ref", "volume": "63", "year": "2023"}, "text": "Molecular Framework Analysis of the Generated Database GDB-13s", "sentences": [], "annotations": [], "relations": []}, {"offset": 29000, "infons": {"fpage": "2", "name_0": "surname:Sorokina;given-names:M.", "name_1": "surname:Merseburger;given-names:P.", "name_2": "surname:Rajan;given-names:K.", "name_3": "surname:Yirik;given-names:M. A.", "name_4": "surname:Steinbeck;given-names:C.", "pub-id_doi": "10.1186/s13321-020-00478-9", "section_type": "REF", "source": "J. Cheminformatics", "type": "ref", "volume": "13", "year": "2021"}, "text": "COCONUT Online: Collection of Open Natural Products Database", "sentences": [], "annotations": [], "relations": []}, {"offset": 29061, "infons": {"fpage": "511", "lpage": "522", "name_0": "surname:Lewell;given-names:X. Q.", "name_1": "surname:Judd;given-names:D. B.", "name_2": "surname:Watson;given-names:S. P.", "name_3": "surname:Hann;given-names:M. M.", "pub-id_doi": "10.1021/ci970429i", "pub-id_pmid": "9611787", "section_type": "REF", "source": "J. Chem. Inf. Comput. Sci.", "type": "ref", "volume": "38", "year": "1998"}, "text": "RECAPs: Retrosynthetic Combinatorial Analysis Procedure: A Powerful New Technique for Identifying Privileged Molecular Fragments with Useful Applications in Combinatorial Chemistry", "sentences": [], "annotations": [], "relations": []}, {"offset": 29242, "infons": {"fpage": "3331", "lpage": "3335", "name_0": "surname:Kruger;given-names:F.", "name_1": "surname:Stiefl;given-names:N.", "name_2": "surname:Landrum;given-names:G. A.", "pub-id_doi": "10.1021/acs.jcim.0c00296", "pub-id_pmid": "32584031", "section_type": "REF", "source": "J. Chem. Inf. Model.", "type": "ref", "volume": "60", "year": "2020"}, "text": "RdScaffoldNetwork: The Scaffold Network Implementation in RDKit", "sentences": [], "annotations": [], "relations": []}, {"offset": 29306, "infons": {"name_0": "surname:Kolb;given-names:P.", "section_type": "REF", "source": "Decomposition and Identification\nof Molecules", "type": "ref", "year": "2010"}, "text": "", "sentences": [], "annotations": [], "relations": []}, {"offset": 29307, "infons": {"fpage": "1503", "lpage": "1507", "name_0": "surname:Degen;given-names:J.", "name_1": "surname:Wegscheid-Gerlach;given-names:C.", "name_2": "surname:Zaliani;given-names:A.", "name_3": "surname:Rarey;given-names:M.", "pub-id_doi": "10.1002/cmdc.200800178", "pub-id_pmid": "18792903", "section_type": "REF", "source": "ChemMedChem.", "type": "ref", "volume": "3", "year": "2008"}, "text": "On the Art of Compiling and Using \u201cDrug-Like\u201d Chemical Fragment Spaces", "sentences": [], "annotations": [], "relations": []}, {"offset": 29382, "infons": {"fpage": "655", "lpage": "667", "name_0": "surname:Heikamp;given-names:K.", "name_1": "surname:Zuccotto;given-names:F.", "name_2": "surname:Kiczun;given-names:M.", "name_3": "surname:Ray;given-names:P.", "name_4": "surname:Gilbert;given-names:I. H.", "pub-id_doi": "10.1111/cbdd.13129", "pub-id_pmid": "29063731", "section_type": "REF", "source": "Chem.\nBiol. Drug Des.", "type": "ref", "volume": "91", "year": "2018"}, "text": "Exhaustive Sampling of the Fragment Space Associated to a Molecule Leading to the Generation of Conserved Fragments", "sentences": [], "annotations": [], "relations": []}, {"offset": 29498, "infons": {"fpage": "627", "lpage": "631", "name_0": "surname:Liu;given-names:T.", "name_1": "surname:Naderi;given-names:M.", "name_2": "surname:Alvin;given-names:C.", "name_3": "surname:Mukhopadhyay;given-names:S.", "name_4": "surname:Brylinski;given-names:M.", "pub-id_doi": "10.1021/acs.jcim.6b00596", "pub-id_pmid": "28346786", "section_type": "REF", "source": "J. Chem. Inf. Model.", "type": "ref", "volume": "57", "year": "2017"}, "text": "Break Down in Order To Build Up: Decomposing Small Molecules for Fragment-Based Drug Design with EMolFrag", "sentences": [], "annotations": [], "relations": []}, {"offset": 29604, "infons": {"fpage": "2081", "lpage": "2083", "name_0": "surname:Ghersi;given-names:D.", "name_1": "surname:Singh;given-names:M.", "pub-id_doi": "10.1093/bioinformatics/btu173", "pub-id_pmid": "24681908", "section_type": "REF", "source": "Bioinformatics", "type": "ref", "volume": "30", "year": "2014"}, "text": "MolBLOCKS: Decomposing Small Molecule Sets and Uncovering Enriched Fragments", "sentences": [], "annotations": [], "relations": []}, {"offset": 29681, "infons": {"section_type": "REF", "source": "Chemaxon", "type": "ref"}, "text": "", "sentences": [], "annotations": [], "relations": []}, {"offset": 29682, "infons": {"fpage": "8", "name_0": "surname:Ertl;given-names:P.", "name_1": "surname:Schuffenhauer;given-names:A.", "pub-id_doi": "10.1186/1758-2946-1-8", "section_type": "REF", "source": "J. Cheminformatics", "type": "ref", "volume": "1", "year": "2009"}, "text": "Estimation of Synthetic Accessibility Score of Drug-like Molecules Based on Molecular Complexity and Fragment Contributions", "sentences": [], "annotations": [], "relations": []}, {"offset": 29806, "infons": {"fpage": "3463", "lpage": "3482", "name_0": "surname:Erlanson;given-names:D. A.", "name_1": "surname:McDowell;given-names:R. S.", "name_2": "surname:O\u2019Brien;given-names:T.", "pub-id_doi": "10.1021/jm040031v", "pub-id_pmid": "15214773", "section_type": "REF", "source": "J. Med. Chem.", "type": "ref", "volume": "47", "year": "2004"}, "text": "Fragment-Based Drug Discovery", "sentences": [], "annotations": [], "relations": []}, {"offset": 29836, "infons": {"fpage": "211", "lpage": "219", "name_0": "surname:Hajduk;given-names:P. J.", "name_1": "surname:Greer;given-names:J.", "pub-id_doi": "10.1038/nrd2220", "pub-id_pmid": "17290284", "section_type": "REF", "source": "Nat. Rev. Drug Discovery", "type": "ref", "volume": "6", "year": "2007"}, "text": "A Decade of Fragment-Based Drug Design: Strategic Advances and Lessons Learned", "sentences": [], "annotations": [], "relations": []}, {"offset": 29915, "infons": {"fpage": "68", "lpage": "74", "name_0": "surname:Ertl;given-names:P.", "name_1": "surname:Roggo;given-names:S.", "name_2": "surname:Schuffenhauer;given-names:A.", "pub-id_doi": "10.1021/ci700286x", "pub-id_pmid": "18034468", "section_type": "REF", "source": "J. Chem. Inf Model", "type": "ref", "volume": "48", "year": "2008"}, "text": "Natural Product-Likeness Score and Its Application for Prioritization of Compound Libraries", "sentences": [], "annotations": [], "relations": []}, {"offset": 30007, "infons": {"fpage": "43", "name_0": "surname:Capecchi;given-names:A.", "name_1": "surname:Probst;given-names:D.", "name_2": "surname:Reymond;given-names:J.-L.", "pub-id_doi": "10.1186/s13321-020-00445-4", "section_type": "REF", "source": "J. Cheminformatics", "type": "ref", "volume": "12", "year": "2020"}, "text": "One Molecular Fingerprint to Rule Them All: Drugs, Biomolecules, and the Metabolome", "sentences": [], "annotations": [], "relations": []}, {"offset": 30091, "infons": {"fpage": "12", "name_0": "surname:Probst;given-names:D.", "name_1": "surname:Reymond;given-names:J.-L.", "pub-id_doi": "10.1186/s13321-020-0416-x", "section_type": "REF", "source": "J. Cheminformatics", "type": "ref", "volume": "12", "year": "2020"}, "text": "Visualization of Very Large High-Dimensional Data Sets as Minimum Spanning Trees", "sentences": [], "annotations": [], "relations": []}, {"offset": 30172, "infons": {"fpage": "2074", "lpage": "2077", "name_0": "surname:Meier;given-names:K.", "name_1": "surname:Ar\u00fas-Pous;given-names:J.", "name_2": "surname:Reymond;given-names:J.-L.", "pub-id_doi": "10.1002/anie.202012049", "section_type": "REF", "source": "Angew. Chem., Int. Ed.", "type": "ref", "volume": "60", "year": "2021"}, "text": "A Potent and Selective Janus Kinase Inhibitor with a Chiral 3D-Shaped Triquinazine Ring System from Chemical Space", "sentences": [], "annotations": [], "relations": []}, {"offset": 30287, "infons": {"fpage": "31", "lpage": "36", "name_0": "surname:Weininger;given-names:D.", "pub-id_doi": "10.1021/ci00057a005", "section_type": "REF", "source": "J. Chem. Inf. Comput. Sci.", "type": "ref", "volume": "28", "year": "1988"}, "text": "SMILES, a Chemical Language and Information System. 1. Introduction to Methodology and Encoding Rules", "sentences": [], "annotations": [], "relations": []}, {"offset": 30389, "infons": {"section_type": "REF", "type": "ref"}, "text": "RDKit: Open-source cheminformatics", "sentences": [], "annotations": [], "relations": []}], "annotations": [], "relations": []}]}]